The Drugs Technical Advisory Board (DTAB) has recommended amendment of the Rules to change Allergan India’s Refresh Tears eye drops from prescription drug to over-the-counter drug, in line with the ...
In a Clinical Study, Patients Report Significant Reduction in Dry Eye Symptoms in Just 30 Days of Usage DUBLIN, Oct. 21, 2015 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results